Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

NOVO NORDISK INC.

Filed by NOVO NORDISK INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 18, 2025
Income
Not reported
Expenses
$2,330,000.00
Filing UUID
70dbf58d-f8bb-46ab-8414-09efaf691c9d
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, General Compounding

Literal federal measure citations: S. 150

BUD · Budget/Appropriations

Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, General Compounding

MMM · Medicare/Medicaid

Obesity, Treat and Reduce Obesity Act, IRA implementation

CPT · Copyright/Patent/Trademark

S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, General Compounding

Literal federal measure citations: S. 150

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.